FOLD - Sangamo rises after trial data for Fabry disease therapy
2025-06-24 08:46:36 ET
More on Sangamo Therapeutics
- Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript
- Sangamo Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation
- Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Sangamo Therapeutics prices $23M securities offering